# Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients

> **NCT05024565** · NA · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 2600 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **BEHAVIORAL:** prolonged intravenous infusion of β-lactams Antibiotics

## Key facts

- **NCT ID:** NCT05024565
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-20
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-09-01
- **Target enrollment:** 2600 (ESTIMATED)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05024565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05024565, "Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05024565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*